GENMAB A/S -SP ADR (GMAB) Forecast, Price Target & Analyst Ratings

NASDAQ:GMAB • US3723032062

Current stock price

27.5 USD
+0.28 (+1.03%)
At close:
27.5 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENMAB A/S -SP ADR (GMAB).

Forecast Snapshot

Consensus Price Target

Price Target
$135.67
+ 393.34% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
$0.18
Revenue Estimate
918.47M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
73.85%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$135.67
Upside
+ 393.34%
From current price of $27.50 to mean target of $135.67, Based on 26 analyst forecasts
Low
$21.08
Median
$126.01
High
$263.69

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

26 Wall Street analysts provided a forecast for the next 12 months for GMAB. The average price target is 95.18 USD. This implies a price increase of 246.12% is expected in the next year compared to the current price of 27.5.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GMAB Current Analyst RatingGMAB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

GMAB Historical Analyst RatingsGMAB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
73.85%
GMAB was analyzed by 26 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about GMAB.
In the previous month the buy percentage consensus was at a similar level.
GMAB was analyzed by 26 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-27Wolfe ResearchInitiate Outperform
2026-03-02Wells FargoInitiate Overweight
2026-02-23GuggenheimMaintains Buy -> Buy
2026-02-18HC Wainwright & Co.Maintains Buy -> Buy
2026-02-17JefferiesReiterate Buy
2026-02-16Morgan StanleyReiterate Equal-Weight
2026-01-28HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-20HC Wainwright & Co.Maintains Buy -> Buy
2025-11-10HC Wainwright & Co.Maintains Buy -> Buy
2025-11-07Truist SecuritiesReiterate Buy -> Buy
2025-10-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-10-02HC Wainwright & Co.Maintains Buy -> Buy
2025-09-24GuggenheimUpgrade Neutral -> Buy
2025-09-23GuggenheimUpgrade Neutral -> Buy
2025-08-15HC Wainwright & Co.Maintains Buy -> Buy
2025-07-08Truist SecuritiesMaintains Buy -> Buy
2025-04-09HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-11William BlairUpgrade Market Perform -> Outperform
2025-03-11Truist SecuritiesMaintains Buy -> Buy
2025-02-13Leerink PartnersUpgrade Market Perform -> Outperform
2025-01-23HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-22HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-08HC Wainwright & Co.Maintains Buy -> Buy
2024-11-08BMO CapitalReiterate Outperform -> Outperform
2024-10-16HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
$0.18
Revenue Estimate
918.47M
Revenue Q2Q
28.46%
EPS Q2Q
-41.61%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
-1.13%
Revenue (3 Months)
-0.26%
EPS (1 Month)
-26.49%
EPS (3 Months)
-51.63%

Next Earnings Summary

GMAB is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 0.18 USD and the consensus revenue estimate is 918.47M USD.
The next earnings revenue estimate has been revised downward by 0.26% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
GMAB revenue by date.GMAB revenue by date.
2.391B
16.63%		3.122B
30.57%		3.72B
19.15%		4.382B
17.80%		5.033B
14.86%		5.94B
18.02%		6.497B
9.38%		6.781B
4.37%		6.784B
0.04%		6.715B
-1.02%		7.175B
6.85%
EBITDA
YoY % growth
GMAB ebitda by date.GMAB ebitda by date.
815.128M
-13.49%		1.087B
33.30%		1.339B
23.23%		1.295B
-3.29%		1.699B
31.20%		2.24B
31.84%		2.523B
12.63%		1.657B
-34.32%		1.996B
20.46%		1.75B
-12.32%		2.249B
28.51%
EBIT
YoY % growth
GMAB ebit by date.GMAB ebit by date.
772.311M
-13.33%		1.027B
32.94%		1.268B
23.50%		1.217B
-4.02%		1.557B
27.94%		2.099B
34.81%		2.116B
0.81%		2.178B
2.93%		2.16B
-0.83%		2.145B
-0.69%		2.376B
10.77%
Operating Margin
GMAB operating margin by date.GMAB operating margin by date.
32.30%32.89%34.09%27.77%30.94%35.34%32.57%32.12%31.84%31.94%33.11%
EPS
YoY % growth
GMAB eps by date.GMAB eps by date.
0.99
-17.57%		1.80
82.09%		1.75
-2.61%		1.49
-15.07%		1.93
30.22%		2.87
48.37%		2.69
-6.18%		2.80
4.04%		3.06
9.35%		3.05
-0.48%		3.41
11.97%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.18
-41.61%		0.36
-35.07%		0.43
-34.38%		0.42
94.54%		0.31
70.10%		0.49
35.36%		0.53
21.03%		0.57
34.15%
Revenue
Q2Q % growth		918.47M
28.46%		1.114B
20.43%		1.176B
15.07%		1.224B
15.69%		1.028B
11.93%		1.194B
7.18%		1.237B
5.19%		1.305B
6.62%
EBITDA
Q2Q % growth		284.92M
39.67%		393.36M
0.35%		452.2M
-11.16%		491.69M
56.59%		N/AN/AN/AN/A
EBIT
Q2Q % growth		173.13M
-7.91%		322.48M
-10.42%		378.64M
-17.51%		408.06M
67.93%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GMAB Yearly Revenue VS EstimatesGMAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
GMAB Yearly EPS VS EstimatesGMAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
17.95%
EPS Next 5 Year
9.88%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
17.06%
Revenue Next 5 Year
12.86%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
19.58%
EBIT Next 5 Year
4.81%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

GENMAB A/S -SP ADR / GMAB Forecast FAQ

What is the average price target for GENMAB A/S -SP ADR (GMAB) stock?

26 analysts have analysed GMAB and the average price target is 95.18 USD. This implies a price increase of 246.12% is expected in the next year compared to the current price of 27.5.

What is the next earnings date for GMAB stock?

GENMAB A/S -SP ADR (GMAB) will report earnings on 2026-05-07.

What are the consensus estimates for GMAB stock next earnings?

The consensus EPS estimate for the next earnings of GENMAB A/S -SP ADR (GMAB) is 0.18 USD and the consensus revenue estimate is 918.47M USD.

Can you provide the expected long term growth rate for GENMAB A/S -SP ADR stock?

The expected long term growth rate for GENMAB A/S -SP ADR (GMAB) is 17.06%.